No Evidence of Disease: Clinical Trials

14 trials for No Evidence of Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 2 terminated, 1 active not recruiting, 1 withdrawn. 6 Not applicable, 3 Phase 1, 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 3, Active not recruiting 1, Terminated 1, Withdrawn 1
Phase 13Completed 3
Phase 22Completed 2
Phase 32Completed 2

Follow No Evidence of Disease: new trials by email Literature Review of No Evidence of Disease trials Research Report on No Evidence of Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivors
Best Practice, Exercise Intervention, Laboratory Biomarker Analysis - Cancer Survivor, Central Obesity
Not applicableWithdrawnUniversity of Southern California2019-03-082020-12-17
Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma
Best Practice, mySmartCheck, Survey Administration - Dysplastic Nevus, Health Status Unknown
Not applicableCompletedRutgers, The State University of New Jersey1162018-11-032022-11-14
Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors
Exercise Intervention, Laboratory Biomarker Analysis, Polar heart rate monitor - Cancer Survivor, No Evidence of Disease
Not applicableTerminatedUniversity of Southern California232017-08-172025-09-29
Oxybutynin Chloride in Managing Hot Flashes
Oxybutynin Chloride, Placebo, Quality-of-Life Assessment - Breast Carcinoma, Ductal Breast Carcinoma In Situ
Phase 3CompletedAcademic and Community Cancer Research United1502016-12-092020-01-18
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission
Laboratory Biomarker Analysis, pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine, Sargramostim - HER2/Neu Negative, No Evidence of Disease
Phase 1CompletedUniversity of Washington322016-09-022024-09-19
MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer
Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis - No Evidence of Disease, Stage II Bladder Cancer
TerminatedUniversity of Southern California102016-03-012022-08-10
Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer Screening
educational intervention, questionnaire administration, quality-of-life assessment - Anxiety, No Evidence of Disease
Not applicableCompletedCity of Hope Medical Center202014-12-082018-09-10
Biomarkers in Post-Menopausal Women Receiving Flaxseed
Clinical Observation, Flaxseed, Laboratory Biomarker Analysis - No Evidence of Disease
Not applicableCompletedRoswell Park Cancer Institute2582012-12-142022-05-09
Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants
Selenium, Placebo, Laboratory Biomarker Analysis - No Evidence of Disease, Prostate Carcinoma
Phase 1CompletedNational Cancer Institute (NCI)662011-11-012014-11-26
Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer
questionnaire administration, survey administration, counseling intervention - No Evidence of Disease, BRCA1 Syndrome
Not applicableActive not recruitingCity of Hope Medical Center4932010-12-022026-10-26
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Bone Marrow Donation, Filgrastim, Laboratory Biomarker Analysis - Healthy Stem Cell Donor, No Evidence of Disease
Phase 3CompletedChildren's Oncology Group132010-06-142020-02-26
Study of 9cUAB30 in Healthy Participants
Laboratory Biomarker Analysis, Pharmacological Study, Retinoid 9cUAB30 - No Evidence of Disease
Phase 1CompletedNational Cancer Institute (NCI)152008-08-012015-06-18
Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers
Celecoxib, Laboratory Biomarker Analysis, UV Light Therapy - No Evidence of Disease
Phase 2CompletedNational Cancer Institute (NCI)252004-03-012016-12-29
Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers
UV Light Therapy, Placebo, Celecoxib - No Evidence of Disease
Phase 2CompletedNational Cancer Institute (NCI)451999-09-012016-12-29

Narrower conditions

Breast Neoplasms (3)  ·  Prostatic Neoplasms (2)  ·  Anxiety Disorders (1)  ·  Breast Carcinoma In Situ (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)  ·  Dysplastic Nevus Syndrome (1)  ·  Hot Flashes (1)  ·  Lung Neoplasms (1)  ·  Melanoma (1)  ·  Obesity (1)  ·  Obesity, Abdominal (1)  ·  Overweight (1)  ·  Sedentary Behavior (1)  ·  Urinary Bladder Neoplasms (1)

Broader conditions

Neoplasms (7)  ·  Neoplasms by Site (7)  ·  Skin Diseases (4)  ·  Skin and Connective Tissue Diseases (4)  ·  Breast Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Urogenital Diseases (3)  ·  Urogenital Neoplasms (3)  ·  Body Weight (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Male (2)  ·  Genital Neoplasms, Male (2)  ·  Neoplasms by Histologic Type (2)

Interventions

Practice Guidelines as Topic (3)  ·  Standard of Care (3)  ·  Celecoxib (2)  ·  Early Intervention, Educational (2)  ·  Methods (2)  ·  Ultraviolet Therapy (2)  ·  Biopsy (1)  ·  Colony-Stimulating Factors (1)  ·  Counseling (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Linseed Oil (1)  ·  Monitoring, Physiologic (1)  ·  Selenium (1)  ·  UAB 30 (1)

Sponsors

National Cancer Institute (NCI) (4)  ·  University of Southern California (3)  ·  City of Hope Medical Center (2)  ·  Academic and Community Cancer Research United (1)  ·  Children's Oncology Group (1)  ·  Roswell Park Cancer Institute (1)  ·  Rutgers, The State University of New Jersey (1)  ·  University of Washington (1)

Countries

United States (14)

Top investigators

Alice Pentland (2)  ·  Christina Dieli-Conwright, Ph.D. (2)  ·  Bita Nehoray (1)  ·  Charles Loprinzi (1)  ·  Dan Raz (1)  ·  Howard Bailey (1)  ·  Jacek Pinski (1)  ·  Kari Wisinski (1)  ·  Raymond Bergan (1)  ·  Sharon Manne, PhD (1)  ·  Spencer Rosario, PhD (1)  ·  Stephan A Grupp (1)

Results publications

PMID 24154719, PMID 34637495, PMID 35261959, PMID 42082270

NIH funding

P30CA014089 (3), P30CA014520 (2), N01CN00033 (1), N01CN35153 (1), N01CN35157 (1), P30CA015083 (1), P30CA060553 (1), P30CA072720 (1), U01CA161809 (1), U10CA098543 (1)